BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1598660)

  • 21. Papillary thyroid carcinoma: factors influencing recurrence and survival.
    Toniato A; Boschin I; Casara D; Mazzarotto R; Rubello D; Pelizzo M
    Ann Surg Oncol; 2008 May; 15(5):1518-22. PubMed ID: 18324441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survival.
    Zidan J; Karen D; Stein M; Rosenblatt E; Basher W; Kuten A
    Cancer; 2003 Mar; 97(5):1181-5. PubMed ID: 12599223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy.
    Vassilopoulou-Sellin R; Schultz PN; Haynie TP
    Cancer; 1996 Aug; 78(3):493-501. PubMed ID: 8697396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Papillary and follicular thyroid cancer: selective therapy.
    Mazzaferri EL
    Compr Ther; 1981 May; 7(5):6-14. PubMed ID: 7016424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.
    Mazzaferri EL; Jhiang SM
    Am J Med; 1994 Nov; 97(5):418-28. PubMed ID: 7977430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term results in elderly patients with differentiated thyroid carcinoma.
    Vini L; Hyer SL; Marshall J; A'Hern R; Harmer C
    Cancer; 2003 Jun; 97(11):2736-42. PubMed ID: 12767085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Papillary and follicular thyroid carcinoma.
    Schlumberger MJ; Torlantano M
    Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Dec; 14(4):601-13. PubMed ID: 11289737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Differentiated thyroid carcinoma, 1972-1992. Follow-up, detection of recurrences and prognostic factors].
    Obiols G; Simó R; Burgos R; Tresserras R; Galofré P; Masmiquel L; Hernández C; Mesa J
    Med Clin (Barc); 1997 Nov; 109(19):738-43. PubMed ID: 9470182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgical treatment of papillary and follicular thyroid carcinoma.
    Lin JD; Jeng LB; Chao TC; Weng HF; Huang HS
    Int Surg; 1996; 81(1):61-6. PubMed ID: 8803709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer.
    Handkiewicz-Junak D; Wloch J; Roskosz J; Krajewska J; Kropinska A; Pomorski L; Kukulska A; Prokurat A; Wygoda Z; Jarzab B
    J Nucl Med; 2007 Jun; 48(6):879-88. PubMed ID: 17536106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients.
    Dottorini ME; Vignati A; Mazzucchelli L; Lomuscio G; Colombo L
    J Nucl Med; 1997 May; 38(5):669-75. PubMed ID: 9170425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thyroid cancer causing death after 40 years: rationale for initial intensive treatment.
    Powell S; Harmer C
    Eur J Surg Oncol; 1990 Oct; 16(5):457-61. PubMed ID: 2209842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of "locally advanced" well-differentiated thyroid carcinomas.
    Falvo L; Catania A; Grilli P; Di Matteo FM; De Antoni E
    Ann Ital Chir; 2004; 75(1):17-21. PubMed ID: 15283382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prospective therapy study in differentiated thyroid carcinoma].
    Gemsenjäger E; Heitz P; Martina B
    Schweiz Med Wochenschr; 1995 Nov; 125(46):2226-36. PubMed ID: 8525342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of the efficacy of iodine-131 for thyroid ablation.
    Comtois R; Thériault C; Del Vecchio P
    J Nucl Med; 1993 Nov; 34(11):1927-30. PubMed ID: 8229236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Reoperation in differentiated carcinoma of the thyroid gland].
    Maffei Faccioli A; Pelizzo MR; Toniato A; Bernante P; Piotto A
    Chir Ital; 1994; 46(4):59-60. PubMed ID: 7882446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
    Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI
    Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute toxicity of adjuvant radiotherapy in locally advanced differentiated thyroid carcinoma. First results of the multicenter study differentiated thyroid carcinoma (MSDS).
    Schuck A; Biermann M; Pixberg MK; Müller SB; Heinecke A; Schober O; Willich N
    Strahlenther Onkol; 2003 Dec; 179(12):832-9. PubMed ID: 14652672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Surgical treatment of differentiated carcinoma of the thyroid. Retrospective study].
    Gutiérrez JM; Fernández A; Eire PF; Mariño JM; Olivas JM; Alonso LA; Peramato PG; Pereira PL; Queizán A; Utrilla JG
    Cir Pediatr; 1990 Apr; 3(2):73-5. PubMed ID: 2252852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of total thyroidectomy for differentiated thyroid carcinoma: a 20-year review.
    Ley PB; Roberts JW; Symmonds RE; Hendricks JC; Snyder SK; Frazee RC; Smith RW; McKenney JF; Brindley GV
    Am Surg; 1993 Feb; 59(2):110-4. PubMed ID: 8476139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.